Follow
Jinyu Li
Jinyu Li
Stony Brook University School of Medicine
Verified email at stonybrook.edu
Title
Cited by
Cited by
Year
Identification of driver genes in hepatocellular carcinoma by exome sequencing
SP Cleary, WR Jeck, X Zhao, K Chen, SR Selitsky, GL Savich, TX Tan, ...
Hepatology 58 (5), 1693-1702, 2013
3392013
Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma
K Revill, T Wang, A Lachenmayer, K Kojima, A Harrington, J Li, Y Hoshida, ...
Gastroenterology 145 (6), 1424-1435. e25, 2013
2572013
Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation
AJ Bott, IC Peng, Y Fan, B Faubert, L Zhao, J Li, S Neidler, Y Sun, N Jaber, ...
Cell metabolism 22 (6), 1068-1077, 2015
2312015
Therapeutic ablation of gain-of-function mutant p53 in colorectal cancer inhibits Stat3-mediated tumor growth and invasion
R Schulz-Heddergott, N Stark, SJ Edmunds, J Li, LC Conradi, ...
Cancer Cell 34 (2), 298-314. e7, 2018
1882018
Elasticity of short DNA molecules: theory and experiment for contour lengths of 0.6–7 μm
Y Seol, J Li, PC Nelson, TT Perkins, MD Betterton
Biophysical journal 93 (12), 4360-4373, 2007
1582007
KRAS drives immune evasion in a genetic model of pancreatic cancer
I Ischenko, S D’Amico, M Rao, J Li, MJ Hayman, S Powers, O Petrenko, ...
Nature communications 12 (1), 1482, 2021
1192021
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4
JM Catanzaro, N Sheshadri, JA Pan, Y Sun, C Shi, J Li, RS Powers, ...
Nature communications 5 (1), 3729, 2014
1032014
Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B
C Cai, M Rajaram, X Zhou, Q Liu, J Marchica, J Li, RS Powers
Cell Cycle 11 (9), 39-47, 2012
862012
System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity
M Rajaram, J Li, M Egeblad, RS Powers
PLoS genetics 9 (9), e1003789, 2013
822013
Development of patient-derived gastric cancer organoids from endoscopic biopsies and surgical tissues
M Gao, M Lin, M Rao, H Thompson, K Hirai, M Choi, GV Georgakis, ...
Annals of surgical oncology 25, 2767-2775, 2018
692018
Two distinct categories of focal deletions in cancer genomes
M Rajaram, J Zhang, T Wang, J Li, C Kuscu, H Qi, M Kato, V Grubor, ...
PLoS One 8 (6), e66264, 2013
582013
Keratin 17 is overexpressed and predicts poor survival in estrogen receptor–negative/human epidermal growth factor receptor-2–negative breast cancer
RD Merkin, EA Vanner, JL Romeiser, ALW Shroyer, LF Escobar-Hoyos, ...
Human Pathology 62, 23-32, 2017
482017
p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression
M Ghosh, S Saha, J Li, DC Montrose, LA Martinez
Molecular cell 83 (2), 266-280. e6, 2023
412023
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)
N Liu-Sullivan, J Zhang, A Bakleh, J Marchica, J Li, D Siolas, S Laquerre, ...
Oncotarget 2 (12), 1254, 2011
222011
Combinatorial CRISPR/Cas9 screening reveals epistatic networks of interacting tumor suppressor genes and therapeutic targets in human breast cancer
X Zhao, J Li, Z Liu, S Powers
Cancer Research 81 (24), 6090-6105, 2021
162021
Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma
J Li, M Chanrion, E Sawey, T Wang, E Chow, A Tward, Y Su, W Xue, ...
PLoS One 10 (3), e0118480, 2015
142015
Entropic elasticity of DNA with a permanent kink
J Li, PC Nelson, MD Betterton
Macromolecules 39 (25), 8816-8821, 2006
142006
Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis–specific targets in a patient with small intestinal neuroendocrine cancer
M Rao, K Oh, R Moffitt, P Thompson, J Li, J Liu, A Sasson, G Georgakis, ...
Molecular Case Studies 6 (2), a004978, 2020
132020
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
T Isermann, ΦΗ Şener, A Stender, L Klemke, N Winkler, A Neesse, J Li, ...
Nature Communications 12 (1), 4019, 2021
122021
Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas
J Li, R Sordella, S Powers
Scientific reports 6 (1), 27891, 2016
82016
The system can't perform the operation now. Try again later.
Articles 1–20